Prix China Health Industries Holdings Inc (CHHE)

China Health Industries Holdings, Inc. engages in the production, marketing, and distribution of medicines, health products, health devices, and cosmetics. The company is headquartered in Harbin, Heilongjiang and currently employs 32 full-time employees. The company went IPO on 2004-12-01. The firm's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The firm's products include soft capsule, hard capsule, tablet, granule, oral liquid forms which address the needs of some key sectors in China, including the feminine, geriatric, and children’s markets.